Effects of LncRNA H19 on Proliferation of Human Colorectal Cancer SW620 Cells

HUO Xiao-lei, PEI Zhen, LI Yong-zhi. et al

Abstract

To determine the expression level of long non-coding RNA (lncRNA) imprinted maternallyexpressed transcript （H19） in colorectal cancer tissues and its effect on proliferation of colorectal cancer SW620 cells. MethodsReal-time quantitative PCR (qRT-PCR) was applied to detect the expression of H19 in 20 paired tumor tissues and adjacent normal tissues, and in normal NCM460 cells and colorectal cancer SW480, HCT116 and SW620 cells. The specific small interfering RNA for H19 (si-H19 group) or negative control sequence (si-NC group) were transfected into SW620 cells. Proliferation of the transfected cells was detected using flow cytometry, CCK8 assay and clone formation experiment. The expressions of CyclinD1 and cyclin dependent kinase 4 (CDK4) were detected by qRT-PCR and Western blot. ResultsThe expression levels of H19 in colorectal cancer tissues and cells were higher compared with those in adjacent normal tissues and normal NCM460 cells. Lower H19 level, cell activities and cell clone numbers were found in si-H19 transfected cells compared with those in si-NC transfected cells ( P<0.05). si-H19transfected cells had decreased expression of CyclinD1 and CDK4 ( P<0.05). ConclusionH19expression in colorectal cancer is high. Knock-down H19 expression can inhibit proliferation of colorectal cancer cells, which provides a potential strategy for targeted therapy of colorectal cancer.

 

Keywords: Long non-coding RNA, Colorectal cancer, Cell proliferation, Therapy 

 

Full Text:

PDF


References


CHEN W, ZHENG R, BAADE PD. Et al. Cancer statistics in China. С A Cancer J Clin. 2016,66(2); 115-132.

SUNKARA V, HEBERT JR. The colorectal cancer mortality-to-incidence ratio as an indicator of global cancer screening and care. Cancer,2015,121 (10); 1563-1569.

BRENNER H, KLOOR M, POX CP. Colorectal cancer. Lancet,2014,383(9927): 1490-1502.

CHEN LL. Linking long noncoding RNA localization and function. Trends Biochem Sci,2016,11(9);761-772.

BEERMANN J, PICCOLI MT. ViereckJ, et al. Non-coding RNAs in development and disease; background, mechanisms, and therapeutic approaches. Physiol Rev,2016, 96(4):1297-1325.

WU Г), OZAKI T, YOSHIHARA Y, et al. Runt-related transcription factor 1 (RUNX1) stimulates tumor suppressor p53 protein in response to DNA damage through complex formation and acetylation. J Biol Chem, 2013, 288(2): 1353- 1364.

ZANG L. YANG F, YUAN JH, et al. Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis,2013 ,34(3) ;577-586.

WANG L, CAI Y, ZHAO X, et al. Down-regulated long non-coding RNA HI9 inhibits carcinogenesis of renal cell carcinoma. Neoplasma.2015,62(3);412-418.

HUANG С. CAO Lt QIU L, et al. Upregulation of H19 promotes invasion and induces epithelial-to-mesenchymal transition in esophageal cancer. Oncol Lett ,2015 .10( 1): 291- 296.

HUARTE M. GUTTMAN M. FELDSER D. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell.2010.142(3) :409- 419.

ZHANG X. Al F. LI X. et al. Inflammation-induced S100A8 activates Id3 and promotes colorectal tumorigenesis. Int J Cancer,2015,137(12) ;2803-2814.

BAZZINI AA, JOHNSTONE TG, CHRISTIANO R. et al. Identification of small ORFs in vertebrates using ribosome footprinting and evolutionary conservation. EMBO J.2014, 33(9):981 -993.

HAN I). GAO X. WANG M, et al. Long noncoding RNA HI9 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3. Oncotarget, 2016,7(16): 22159-22173.

KONG H, WU Y. ZHU M, et al. Long non-coding RNAs: novel prognostic biomarkers for liver metastases in patients with early stage colorectal cancer. Oncotarget, 2016 , 7 ( 31): 50428-50436.

BALKWILL F, MANTOVANI A. Cancer and inflammation: implications for pharmacology and therapeutics. Clin Pharmacol Ther,2010,87(4):401-406.

LIANG WC, FU WM. WONG CW, et al. The IncRNA HI 9 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer. Oncotarget, 2015,6(26): 22513-22525.

SCHWARTZ GK, SHAH MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol,2005,23(36); 9408-9421.


Refbacks

  • There are currently no refbacks.